Umeclidinium-vilanterol is associated with improved clinical outcomes in symptomatic patients with chronic obstructive pulmonary disease.

Mepolizumab reduces moderate to severe COPD exacerbations in patients with varying blood eosinophil counts and type 2 ...

For four additional disease-free years, participants could tack on an average 24 extra minutes of sleep per night, about four ...

New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are ...

Results showed that a dry powder inhaler loaded with umeclidinium and vilanterol produced a 14% lower risk of moderate or severe COPD flare-ups, compared to a metered-dose inhaler loaded with ...

Cough sounds carry disease-specific acoustic signatures. By analysing these signatures using an AI-based algorithm, the ...

New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are not only less harmful to the environment but can also lead to slightly ...

Vitality Medical reports that a state analysis shows respiratory care demand varies widely, with the South having high burden but low purchasing.

An artificial intelligence-powered mobile application developed by a Karnataka-based startup and validated by AIIMS may soon ...

Anoro Elipta may be better than Bevespi Aerosphere or Stiolto Respimat at lowering risk of chronic obstructive pulmonary lung disease flares.